Ameriprise Financial Inc. boosted its holdings in shares of Columbia Research Enhanced Core ETF (NYSEARCA:RECS) by 1.8% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 13,203,009 shares of the company's stock after purchasing an additional 239,164 shares during the period. Ameriprise Financial Inc.
Columbia Research Enhanced Core ETF tracks the index comprising the Russell 1000 constituents that demonstrate a convincing combination of quality, value, and catalyst factors. I maintain the Buy rating on RECS, owing to its robust performance (i.e., alpha delivered in 2025) and a GARP tilt manifested in a 1.15 PEG ratio. Risks include the AI economy names underdelivering, as well as higher inflation and slower-than-expected interest rate cuts.
Columbia Threadneedle Investments just released six new ETFs, including five which are actively managed and one tied to an index. All funds target specific segments in the equities as well as the fixed income market.
RECS has an index-based strategy designed to benefit from the worthiest names in the Russell 1000 index. In April 2022, I assigned a Hold rating to it owing to the small AUM and unideal liquidity. These concerns have been dissolved. RECS' performance has been nothing short of impressive, as it has beaten both IVV and IWB.
Columbia Research Enhanced Core ETF selects stocks in the Russell 1000 based on quality and value, keeping the same sector breakdown as the parent index. The RECS ETF has outperformed the Russell 1000 since inception, and shows better value and growth metrics. Moreover, RECS has outperformed some of the best quality and value ETFs since its inception in 2019.